---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-25-002335"
form_type: "8-K/A"
ticker: "SLXN"
cik: "0002022416"
company_name: "Silexion Therapeutics Corp"
filed_at: "2025-07-08T23:59:59+00:00"
generated_at: "2026-05-18T09:09:22.714143+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Silexion amends 8-K, delays Nasdaq transfer; reverse split expected in August to cure bid price deficiency

## Summary
- Nasdaq transfer to Capital Market not on July 8 as originally reported; now expected as soon as practicable.
- Shareholder vote on 1-for-15 reverse split reconvenes July 14, 2025 at annual meeting.
- After approval, 10-day Nasdaq notice period ends ~July 25; then 10 consecutive trading days above $1.00 needed.
- Compliance with minimum bid price rule expected early to mid-August; no assurance of success.

## SEC filing metadata
- accession: 0001178913-25-002335
- form_type: 8-K/A
- ticker: SLXN
- cik: 0002022416
- company_name: Silexion Therapeutics Corp
- filed_at: 2025-07-08T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2022416/000117891325002335/0001178913-25-002335-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2022416/000117891325002335/zk2533427.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-25-002335
- JSON: https://secwatch.observer/filing/0001178913-25-002335.json
- Plain text: https://secwatch.observer/filing/0001178913-25-002335.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.